Knowles D M
Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY 10032.
Semin Oncol. 1993 Dec;20(6):583-610.
Distinguishing benign and malignant lymphoproliferative disorders by purely morphologic criteria can be difficult. Immunophenotypic analysis is a useful adjunct to the morphologic evaluation of lymphoproliferative disorders and is of considerable assistance in resolving difficult diagnostic dilemmas. Immunophenotypic analysis can be performed on virtually any pathologic specimen using a variety of methodologic approaches. The analysis should be tailored to the individual pathologic specimen and the specific diagnostic problem. The results should be correlated with the clinical and morphologic findings. Southern blot hybridization analysis of the antigen receptor genes has proven to be an objective, accurate, and sensitive method by which to determine the lineage and clonality of lymphoid proliferations and to detect clonal B- and T-cell populations that are not recognizable morphologically or immunophenotypically. Polymerase chain reaction-based strategies extraordinarily more sensitive than Southern blotting are currently being developed. However, the demonstration of clonal antigen receptor gene rearrangements is an indication of clonality and not necessarily of malignancy, although the two are closely related. This and all the other biologic and technical limitations of immunogenotypic analysis must be considered when evaluating the results of such studies. Ideally, the results of immunogenotypic analysis should be interpreted only in conjunction with the results of morphologic evaluation and immunophenotypic analysis.
单纯依靠形态学标准来区分良性和恶性淋巴增殖性疾病可能会很困难。免疫表型分析是淋巴增殖性疾病形态学评估的有用辅助手段,在解决诊断难题方面有很大帮助。免疫表型分析几乎可以使用各种方法对任何病理标本进行。分析应根据个体病理标本和具体诊断问题进行调整。结果应与临床和形态学发现相关联。抗原受体基因的Southern印迹杂交分析已被证明是一种客观、准确且灵敏的方法,可用于确定淋巴增殖的谱系和克隆性,并检测形态学或免疫表型无法识别的克隆性B细胞和T细胞群体。目前正在开发比Southern印迹法灵敏度高得多的基于聚合酶链反应的策略。然而,克隆性抗原受体基因重排的证明表明存在克隆性,但不一定意味着恶性,尽管两者密切相关。在评估此类研究结果时,必须考虑免疫基因型分析的这一以及所有其他生物学和技术局限性。理想情况下,免疫基因型分析结果应仅结合形态学评估和免疫表型分析结果进行解释。